Socías ME, Dickhout P, Langlois J, Grant C, Nolan S Extended-release injectable buprenorphine for the treatment of opioid use disorder among individuals at high risk of overdose: the FASTER-BUP udy [sic] Drug Alcohol Depend PubMed

Tobias S, Tu A, Shapiro AM, Mérette SAM, Lysyshyn M, Wood E, Buxton JA, Ti L Fentanyl concentrations in unregulated opioids and the blood of drug toxicity decedents AJE Adv Link

Jackson E, Bach P, Socías ME, Brooks OM, Fairbairn N, Rodrigues M, Rosic T, Naji L, Jinks-Chang S, Nolan S, Chesney A, Reshetukha T, Samaan Z, Dennis B Trends in stimulant use among patients with opioid use disorder receiving substance use treatment: findings from a prospective cohort study from 2013 to 2020 Drug Alcohol Depend PubMed

Mayer S, Fairbairn N, Fowler A, Boyd J, Kerr T, McNeil R Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada Harm Reduct J PubMed

Langlois J, Fairbairn N, Jutras-Aswad D, Le Foll B, Ahamad K, Lim R, Socías ME Comparative effectiveness of buprenorphine/naloxone and methadone on methamphetamine/amphetamine use among people with opioid use disorder in Canada Subst Use Addctn J PubMed

Zazoulina J, Nolan S, Fairbairn N, Ryan A, Dennis BB, Bach P Intravenous fentanyl for symptom management in hospitalized patients with refractory opioid withdrawal: a retrospective cohort study J Addict Med PubMed

Mihic T, Fairbairn N, Nolan S, Dagenais R, Quon B, Socías ME Use of buprenorphine/naloxone in an adult with cystic fibrosis Can J Hosp Pharm PubMed

Ti L, Mihic T, Beauchesne A, Grant C, Frank I, Haji N, Legal M, Shalansky S, Nolan S Evaluation of a hospital-based opioid stewardship program on high-risk opioid prescribing in a Canadian setting: an interrupted time series analysis Addict Sci Clin Pract PubMed

Young S, Fairbairn N, Cui Z, Bach P, Mok WY, Budau J, Slaunwhite A, Ti L, Hayashi K, Nolan S Association between prescribed stimulant medications and overdose among individuals receiving opioid agonist therapy: a retrospective cohort study from British Columbia, Canada Addiction PubMed

Tobias S, Angelucci J, Wood E, Buxton JA, Ti L Novel adulterants in unregulated opioids and their associations with adverse events Can J Public Health PubMed